Patents by Inventor Alexandre Gagnon

Alexandre Gagnon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for automatically tagging documents with matrix barcodes and providing access to a plurality of said document versions
    Patent number: 10242004
    Abstract: A method of tagging a document for future access, the method comprising the steps of: (a) Saving a document on a server, (b) Accessing said document by a tagging process program, (c) Having said tagging process program: (i) generate a tag referring to the location of said document on said server; and (ii) add said tag to said document, while said tag being visible on the printed version of the document, wherein, said tag can be scanned by a device equipped with an optical scanner and as a result said document would be accessible to said device.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: March 26, 2019
    Assignee: Knova Web Technologies, Inc.
    Inventors: Gabriel Deschenes, Alexandre Gagnon-Demers, Julien Leroux
  • METHOD FOR AUTOMATICALLY TAGGIN DOCUMENTS WITH MATRIX BARCODES AND PROVIDING ACCESS TO A PLURALITY OF SAID DOCUMENT VERSIONS
    Publication number: 20170322932
    Abstract: A method of tagging a document for future access, the method comprising the steps of: (a) Saving a document on a server, (b) Accessing said document by a tagging process program, (c) Having said tagging process program: (i) generate a tag referring to the location of said document on said server; and (ii) add said tag to said document, while said tag being visible on the printed version of the document, wherein, said tag can be scanned by a device equipped with an optical scanner and as a result said document would be accessible to said device.
    Type: Application
    Filed: March 21, 2017
    Publication date: November 9, 2017
    Applicant: Knova Web Technologies, Inc.
    Inventors: Gabriel DESCHENES, Alexandre GAGNON-DEMERS, Julien LEROUX
  • Modulators of methyl modifying enzymes, compositions and uses thereof
    Patent number: 9409865
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: August 9, 2016
    Assignee: Constellation_Pharmaceuticals, Inc.
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • Modulators of methyl modifying enzymes, compositions and uses thereof
    Patent number: 9206128
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: December 8, 2015
    Assignee: Constellation Pharmaceuticals, Inc.
    Inventors: Brian K. Albrecht, James Edmund Audia, Andrew S. Cook, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
    Publication number: 20150315148
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Application
    Filed: May 8, 2015
    Publication date: November 5, 2015
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • Modulators of methyl modifying enzymes, compositions and uses thereof
    Patent number: 9051269
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: June 9, 2015
    Assignee: Constellation Pharmaceuticals, Inc.
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • Viral polymerase inhibitors
    Patent number: 8912182
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: December 16, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Pierre L. Beaulieu, Pasquale Forgione, Alexandre Gagnon, Cedrickx Godbout, Marc-Andre Joly, Montse Llinas-Brunet, Julie Naud, Martin Poirier, Jean Rancourt
  • METHOD FOR AUTOMATICALLY TAGGING DOCUMENTS WITH MATRIX BARCODES AND PROVIDING ACCESS TO A PLURALITY OF SAID DOCUMENT VERSIONS
    Publication number: 20140331335
    Abstract: A method of tagging a document for future access, the method comprising the steps of: (a) Saving a document on a server, (b) Accessing said document by a tagging process program, (c) Having said tagging process program: (i) generate a tag referring to the location of said document on said server; and (ii) add said tag to said document, while said tag being visible on the printed version of the document, wherein, said tag can be scanned by a device equipped with an optical scanner and as a result said document would be accessible to said device.
    Type: Application
    Filed: February 17, 2012
    Publication date: November 6, 2014
    Applicant: KNOVA WEB TECHNOLOGIES, INC.
    Inventors: Gabriel Deschenes, Alexandre Gagnon-Demers, Julien Leroux
  • MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
    Publication number: 20140315949
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Application
    Filed: November 19, 2012
    Publication date: October 23, 2014
    Applicant: CONSTELLATION PHARMACEUTICALS, INC.
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
    Publication number: 20140288123
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Application
    Filed: November 19, 2012
    Publication date: September 25, 2014
    Inventors: Brian K. Albrecht, James Edmund Audia, Andrew Cook, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Nasveschuk
  • VIRAL POLYMERASE INHIBITORS
    Publication number: 20130331391
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: August 15, 2013
    Publication date: December 12, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Pierre L. BEAULIEU, Pasquale FORGIONE, Alexandre GAGNON, Cedrickx GODBOUT, Marc-Andre JOLY, Montse LLINAS-BRUNET, Julie NAUD, Martin POIRIER, Jean RANCOURT
  • MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
    Publication number: 20130310379
    Abstract: Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
    Type: Application
    Filed: November 21, 2011
    Publication date: November 21, 2013
    Applicant: CONSTELLATION PHARMACEUTICALS
    Inventors: Brian K. Albrecht, James Edmund Audia, Alexandre Gagnon, Jean-Christophe Harmange, Christopher G. Naveschuk
  • Viral polymerase inhibitors
    Patent number: 8541402
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: September 24, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Pierre L. Beaulieu, Pasquale Forgione, Alexandre Gagnon, Cedrickx Godbout, Marc-Andre Joly, Montse Llinas-Brunet, Julie Naud, Martin Poirier, Jean Rancourt
  • Viral polymerase inhibitors
    Patent number: 8476257
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: July 2, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Pierre L. Beaulieu, Pasquale Forgione, Alexandre Gagnon, Cedrickx Godbout, Marc-Andre Joly, Montse Llinas-Brunet, Julie Naud, Martin Poirier, Jean Rancourt
  • VIRAL POLYMERASE INHIBITORS
    Publication number: 20120214783
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: May 3, 2012
    Publication date: August 23, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Pierre L. BEAULIEU, Pasquale FORGIONE, Alexandre GAGNON, Cedrickx GODBOUT, Marc-Andre JOLY, Montse LLINAS-BRUNET, Julie NAUD, Martin POIRIER, Jean RANCOURT
  • Non-nucleoside reverse transcriptase inhibitors
    Patent number: 8198458
    Abstract: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: June 12, 2012
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Patrick DeRoy, Anne-Marie Faucher, Alexandre Gagnon, Serge R. Landry, Sebastien Morin, Jeffrey O'Meara, Bruno Simoneau, Bounkham Thavonekham, Christiane Yoakim
  • Inhibitors of HIV replication
    Patent number: 8039638
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV replication, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: October 18, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christiane Yoakim, Patrick Deroy, Martin Duplessis, Alexandre Gagnon, Sylvie Goulet, Oliver Hucke, Christopher Lemke, Simon Suprenant
  • VIRAL POLYMERASE INHIBITORS
    Publication number: 20110021486
    Abstract: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: December 3, 2008
    Publication date: January 27, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Pierre L. Beaulieu, Pasquale Forgione, Alexandre Gagnon, Cedrickx Godbout, Marc-Andre Terrebonne, Montse Llinas-Brunet, Julie Naud, Martin Poirier, Jean Rancourt
  • VIRAL POLYMERASE INHIBITORS
    Publication number: 20100286131
    Abstract: Compounds of formula I: wherein, R2, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
    Type: Application
    Filed: July 31, 2008
    Publication date: November 11, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Pierre L. Beaulieu, Pasquale Forgione, Alexandre Gagnon, Cedrickx Godbout, Julie Naud, Martin Poirier, Jean Rancourt, Timothy A. Stammers, Bounkham Thavonekham
  • INHIBITORS OF HIV REPLICATION
    Publication number: 20100069353
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV replication, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: December 3, 2007
    Publication date: March 18, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christiane Yoakim, Patrick Deroy, Martin Duplessis, Alexandre Gagnon, Sylvie Goulet, Oliver Huecke, Christopher Lemke, Simon Surprenant